Letter to the editor: "Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia"

被引:0
作者
Kaamini, E. [1 ]
Santhoshkumar, Murali [1 ]
机构
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Med Coll & Hosp, Ctr Global Hlth Res, Chennai, Tamil Nadu, India
关键词
Subarachnoid hemorrhage; Cerebral vasospasm; Personalized medicine; Pharmacogenomics; Neuroprotection;
D O I
10.1007/s10143-024-02694-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This letter commends the article by Luzzi et al. on alternative neuroprotection strategies for aneurysmal subarachnoid hemorrhage (SAH). It highlights the pharmacological advantages of nicardipine, cilostazol, and clazosentan over nimodipine in managing cerebral vasospasm and delayed cerebral ischemia. Emphasizing the need for personalized medicine, it advocates for integrating genetic screening and advanced monitoring techniques to tailor treatments to individual patient profiles. This approach could significantly improve clinical outcomes by optimizing drug efficacy and minimizing adverse effects.
引用
收藏
页数:2
相关论文
共 5 条
  • [1] Kiser Tyree H, 2013, Hosp Pharm, V48, pS2, DOI 10.1310/hpj48S5-S2
  • [2] Letter to the editor: "Association of hemoglobin drift and outcomes in patients with aneurysmal subarachnoid hemorrhage"
    Kubendiran, Lavanya
    [J]. NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [3] Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia
    Luzzi, Sabino
    Bektasoglu, Pinar Kuru
    Dogruel, Yucel
    Gungor, Abuzer
    [J]. NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [4] Nimodipine Pharmacokinetic Variability in Various Patient Populations
    Mahmoud, Sherif Hanafy
    Ji, Xinqi
    Isse, Fadumo Ahmed
    [J]. DRUGS IN R&D, 2020, 20 (04) : 307 - 318
  • [5] Park Ji-Young, 2014, Translational and Clinical Pharmacology, V22, P3